NDC 0010-6014-02 - Metacam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0010-6014
- Requested NDC
- 0010-6014-02
- Package NDCs from labels
- 0010-6014-01, 0010-6014-02
- Manufacturer
- Boehringer Ingelheim Animal Health USA Inc.
- Effective date
- 2025-05-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metacam ® (meloxicam oral suspension) 0.5 mg/mL | Boehringer Ingelheim Animal Health USA Inc. | 2025-05-02 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0010-6014-01 | Metacam | 15 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 15 | 13 | |
| 0010-6014-01 | Metacam | 1 in 1 CARTON | SUSPENSION | 1 | 13 | |
| 0010-6014-02 | Metacam | 30 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 30 | 13 | |
| 0010-6014-02 | Metacam | 1 in 1 CARTON | SUSPENSION | 1 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MELOXICAM | ACTIVE INGREDIENT | VG2QF83CGL | METACAM (MELOXICAM) SUSPENSION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 3 | |
| MELOXICAM | ACTIVE MOIETY | VG2QF83CGL | METACAM (MELOXICAM) SUSPENSION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lights Lemon Glycerin | GLYCERIN | Lights Medical Manufacture Co., Ltd. | c38638af-f367-4780-8295-022d959e79ca | 2026-11-09 | Warnings | PDC6A3C0OX |
| BEVERHILL HAIR TONIC | UNDARIA PINNATIFIDA EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, MORUS ALBA BARK EXTRACT, PINUS DENSIFLORA LEAF EXTRACT, ARTEMISIA VULGARIS EXTRACT, SESAMUM INDICUM SEED EXTRACT, SODIUM BENZOATE | BIOHERB Co., Ltd. | 32733977-606e-f110-e063-6294a90aba8f | 2026-11-06 | Warnings | OJ245FE5EU |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | PDC6A3C0OX |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2026-11-03 | Warnings | PDC6A3C0OX |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Shield Line LLC | 5f635795-cb5b-cab4-e063-6394a90a7a9a | 2026-11-03 | Warnings | PDC6A3C0OX |
| Huddle Barrier Balm | GLYCERIN | Better Barrier Co. | 5b3cf1ed-082b-15cf-e063-6394a90a688e | 2026-11-02 | Warnings | PDC6A3C0OX |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445dc4f6-daac-e2f1-e063-6394a90a0ca5 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 453c5328-090e-0159-e063-6394a90a06b7 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445d7cbf-bd3e-a54f-e063-6294a90a67a5 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 7895f389-1509-4e03-8668-526ab1627fc8 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 2322a070-25f0-4fc6-a98e-44ad1fb52dc5 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.